8-K 1 e18051_8k.txt FORM 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 25, 2004 PhotoMedex, Inc. -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 0-11635 59-2858100 ---------------------------- ---------------- ------------------- (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 147 Keystone Drive, Montgomeryville, PA 18936 ---------------------------------------- ------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code 215.619.3600 -------------------------------------------------------------------------------- (Former name or former address if changed since last report) ================================================================================ Item 9. Regulation FD Disclosure On May 25, 2004, the Registrant announced that Aetna, a private health plan, had approved for reimbursement procedures using the XTRAC(R) excimer laser to treat psoriasis. The Information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12 (a) (2) of the Securities Act of 1933, as amended. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PhotoMedex, Inc. Date: May 27, 2004 By: /s/ Dennis M. McGrath --------------------------- Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Subject Matter Press release of PhotoMedex, Inc. 99.1 PhotoMedex Press Release dated May 25, 2004, reporting the announcement that Aetna Adopts Reimbursement for PhotoMedex XTRAC(R) 3